PERIPHERAL NEUROPATHY
Clinical trials for PERIPHERAL NEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL NEUROPATHY trials appear
Sign up with your email to follow new studies for PERIPHERAL NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can silicone pads replace foam to stop diabetic foot ulcers?
Disease control Not yet recruitingThis study compares silicone pads to felted foam for reducing pressure under the foot in people with diabetes and nerve damage who are at high risk of foot ulcers. About 80 participants will wear each type of pad, and researchers will measure how well they lower pressure and how …
Matched conditions: PERIPHERAL NEUROPATHY
Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Allergy pill may shield breast cancer patients from chemo nerve pain
Prevention Not yet recruitingThis study tests whether desloratadine, a common allergy medicine, can prevent or reduce nerve damage (peripheral neuropathy) caused by taxane chemotherapy in breast cancer patients. About 116 people will receive either desloratadine or a placebo during their 12-week chemo course…
Matched conditions: PERIPHERAL NEUROPATHY
Phase: PHASE2 • Sponsor: Montefiore Medical Center • Aim: Prevention
Last updated May 07, 2026 18:41 UTC
-
Wearable gadget aims to steady shaky steps in nerve damage patients
Symptom relief Not yet recruitingThis study tests a wearable device designed to improve balance and walking in adults with peripheral neuropathy, a condition that causes numbness and weakness in the feet and legs. About 80 participants will use the device at home and attend weekly sessions to see if it helps the…
Matched conditions: PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: MYNERVA AG • Aim: Symptom relief
Last updated May 17, 2026 08:55 UTC
-
Acupuncture and exercise may ease chemo nerve pain in bladder cancer
Symptom relief Not yet recruitingThis study tests whether adding acupuncture to virtual exercise can reduce nerve pain caused by chemotherapy in people with advanced bladder cancer. About 50 participants will either do acupuncture plus virtual exercise or just virtual exercise. The goal is to see if this combina…
Matched conditions: PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 17, 2026 08:53 UTC
-
New hope for diabetic nerve pain: 28-Day supplement trial launches
Symptom relief Not yet recruitingThis study tests whether an oral supplement called DLBS1033 can reduce nerve damage and inflammation in adults with diabetic polyneuropathy—a common complication of type 2 diabetes causing pain and numbness. Thirty-four participants will take either the supplement plus standard c…
Matched conditions: PERIPHERAL NEUROPATHY
Phase: PHASE2, PHASE3 • Sponsor: Universitas Sebelas Maret • Aim: Symptom relief
Last updated May 17, 2026 08:45 UTC
-
Simple exercises may ease chemo nerve pain
Symptom relief Not yet recruitingThis study tests whether a 15-minute hand and foot exercise routine can reduce nerve pain, numbness, and tingling caused by chemotherapy in cancer patients. 58 adults aged 20-60 with mild nerve symptoms will either do the exercises plus standard care or standard care alone. Resea…
Matched conditions: PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: University of Health Sciences Lahore • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC
-
Simple hand and foot exercises may ease chemo nerve pain in older cancer patients
Symptom relief Not yet recruitingThis study looks at whether hand and foot exercises can reduce nerve pain (like numbness and tingling) caused by chemotherapy in older adults with gynecological cancer. About 74 people aged 65 and older will take part. The goal is to see if these exercises improve their quality o…
Matched conditions: PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Symptom relief
Last updated May 11, 2026 20:51 UTC